Skip to main content

Tango Therapeutics, Inc 10-K for FY2022

Tango Therapeutics, Inc. (TNGX)

10-K 2023-03-27 For: 2022-12-31
View Original
Added on April 08, 2026

About this 10-K

Tango Therapeutics, Inc filed this 10-K on March 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$24.86M
down 32.9% from $37.04M a year earlier
Net loss
$108.18M
compared with a net loss of $58.24M a year earlier
Diluted EPS
-$1.23
compared with -$0.94 a year earlier